NF-κB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages

Molecular Biology of the Cell

Volumn 10, Issue 2, 1999, Pages 361-372

  Von Knethen, Andreas ^a   Callsen, Dagmar ^a   Brüne, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; N(G) METHYLARGININE; NITRIC OXIDE; PHOSPHOTRANSFERASE; S NITROSOGLUTATHIONE; TRANSCRIPTION FACTOR AP 1; DRUG DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; GLUTATHIONE; ISOENZYME; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; OLIGODEOXYRIBONUCLEOTIDE; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN P53; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CYTOKINE RELEASE; ENZYME ACTIVITY; GENETIC TRANSFECTION; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; MACROPHAGE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALIA; MURINAE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CYCLOOXYGENASE 2; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION; GLUTATHIONE; INTERFERON-GAMMA, RECOMBINANT; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; OLIGODEOXYRIBONUCLEOTIDES; OMEGA-N-METHYLARGININE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; S-NITROSOGLUTATHIONE; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032587545     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.2.361     Document Type: Article

References (59)

1. Albina, J.E., Cui, S., Mateo, R.B., and Reichner, J.S. (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150, 5080-5085.
2. Ambs, S., Hussain, S.P., and Harris, C.C. (1997). Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11, 443-448.
3. Anderson, M.T., Staal, F.J., Gitler, C., and Herzenberg, L.A. (1994). Separation of oxidant-initiated and redox-regulated steps in the NF-κ B signal transduction pathway. Proc. Natl. Acad. Sci. USA 91, 11527-11531.
4. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P., and Karin, M. (1987). Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739.
5. Arakawa, T., Laneuville, O., Miller, C.O., Lakkides, K.M., Wingerd, B.A., DeWitt, D.L., and Smith, W.L. (1996). Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells - structure and expression of the murine prostaglandin EP4 receptor gene. J. Biol. Chem. 271, 29569-29575.
6. Bach, F.K., Ferran, C., Hechenleitner, P., Mark, W., Koyamada, N., Miyatake, T., Winkler, H., Badrichani, A., Candinas, D., and Hancock, W.W. (1997). Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. 3, 196-204.
7. Baeuerle, P.A., and Baltimore, D. (1996). NF-κ B: ten years after. Cell 87, 13-20.
8. Baichwal, V.R., and Baeuerle, P.A. (1997). Activate NF-kappaB or die? Curr. Biol. 7, 94-96.
9. Brown, P.H., Alani, R., Preis, L.H., Szabo, E., and Birrer, M.J. (1993). Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8, 877-886.
10. Brown, P.H., Chen, T.K., and Birrer, M.J. (1994). Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9, 791-799.
11. Burton, K. (1956). A study of the conditions and mechanism of the diphenylamine reaction for the estimation of DNA. Biochem. J. 62, 315-323.
12. Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P.A., and Poli, G. (1996). Nuclear factor κ B is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 229, 643-647.
13. Hempel, S.L., Monick, M.M., He, B., Yano, T., and Hunninghake, G.W. (1994). Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone. J. Biol. Chem. 269, 32979-32984.
14. Hierholzer, C., Harbrecht, B., Menezes, J.M., Kane, J., MacMicking, J., Nathan, C.F., Peitzman, A.B., Billiar, T.R., and Tweardy, D.J. (1998). Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med. 187, 917-928.
15. Hwang, D., Jang, B.C., Yu, G., and Boudreau, M. (1997). Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem. Pharmacol. 54, 87-96.
16. Ignarro, L.J. (1990). Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30, 535-560.
17. Jacobson, M.D. (1996). Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21, 83-86.
18. Karin, M., Liu, Z., and Zandi, E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
19. Lander, H.M. (1997). An essential role for free radicals and derived species in signal transduction. FASEB J. 11, 118-124.
20. Lander, H.M., Sehajpal, P., Levine, D.M., and Novogrodsky, A. (1993). Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150, 1509-1516.
21. Landino, L.M., Crews, B.C., Timmons, M.D., Morrow, J.D., and Marnett, L.J. (1996). Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 93, 15069-15074.
22. Levy, G.N. (1997). Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer. FASEB J. 11, 234-247.
23. Lin, Y.-C, Brown, K., and Siebenlist, U. (1995). Activation of NF-kappaB requires proteolysis of the inhibitor IkappaB-α: signal-induced phosphorylation of IkappaB-α alone does not release active NF-kappaB. Proc. Natl. Acad. Sci. USA 92, 552-556.
24. McConkey, D.J., Nicotera, P., Hartzell, P., Bellomo, G., Wyllie, A.H., and Orrenius, S. (1989). Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch. Biochem. Biophys. 269, 365-370.
25. Menon, S.D., Guy, G.R., and Tan, Y.H. (1995). Involvement of a putative protein-tyrosine phosphatase and I κ B-α serine phosphorylation in nuclear factor κ B activation by tumor necrosis factor. J. Biol. Chem. 270, 18881-18887.
26. Messmer, U.K., and Brüne, B. (1996). Nitric oxide (NO) in apoptotic versus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD+ content, and p53 accumulation. Arch. Biochem. Biophys. 327, 1-10.
27. Messmer, U.K., Lapetina, E.G., and Brüne, B. (1995). Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47, 757-765.
28. Messmer, U.K., Reimer, D.M., Reed, J.C., and Brüne, B. (1996). Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett. 384, 162-166.
29. Nathan, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
30. Newton, R., Kuitert, L.M.E., Bergmann, M., Adcock, I.M., and Barnes, P.J. (1997). Evidence for involvement of NF-κB in the transcriptional control of Cox-2 gene expression by IL-1β. Biochem. Biophys. Res. Commun. 237, 28-32.
31. Nüssler, A.K., and Billiar, T.R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54, 171-178.
32. Park, S.K., Lin, H.L., and Murphy, S. (1997). Nitric oxide regulates nitric synthase-2 gene expression by inhibiting NF-κ B binding to DNA. Biochem. J. 322, 609-613.
33. Pilz, R.B., Suhasini, M., Idriss, S., Meinkoth, J.L., and Boss, G.R. (1995). Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9, 552-558.
34. Quijano, C., Alvarez, B., Gatti, R.M., Augusto, O., and Radi, R. (1997). Pathways of peroxynitrite oxidation of thiol groups. Biochem. J. 322, 167-173.
35. Robinson, M.J., and Cobb, M.H. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9, 180-186.
36. Roshak, A.K., Jackson, J.R., McGough, K., Chabot Fletcher, M., Mochan, E., and Marshall, L.A. (1996). Manipulation of distinct NFkappaB proteins alters interleukin-1β-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem. 271, 31496-31501.
37. Salvemini, D., Currie, M.G., and Mollace, V. (1996). Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J. Clin. Invest. 97, 2562-2568.
38. Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, M.G., and Needleman, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90, 7240-7244.
39. Sandau, K., and Brüne, B. (1996). The dual role of S-nitrosoglutathione (GSNO) during thymocyte apoptosis. Cell. Signal. 8, 173-177.
40. Sarih, M., Souvannavong, V., and Adam, A. (1993). Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191, 503-508.
41. Schmedtje, J.F., Liu, W.L., DuBois, R.N., and Runge, M.S. (1997). Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272, 601-608.
42. Schoonbroodt, S., Legrand Poels, S., Best Belpomme, M., and Piette, J. (1997). Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 321, 777-785.
43. Sciorati, C., Nistico, G., Meldolesi, J., and Clementi, E. (1997). Nitric oxide effects on cell growth. GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br. J. Pharmacol. 122, 687-697.
44. Sharma, H.W., Perez, J.R., Higgins Sochaski, K., Hsiao, R., and Narayanan, R. (1996). Transcription factor decoy approach to decipher the role of NF-κ B in oncogenesis. Anticancer Res. 16, 61-69.
45. Sheng, H., Shao, J., Kirkland, S.C., Isakson, P., Coffey, R.J., Morrow, J., Beauchamp, R.D., and DuBois, R.N. (1997). Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99, 2254-2259.
46. Stamler, J.S. (1994). Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78, 931-936.
47. Tetsuka, T., Daphna Iken, D., Miller, B.W.,Guan, Z., Baier, L.D., and Morrison, A.R. (1996a). Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97, 2051-2056.
48. Tetsuka, T., Srivastava, S.K., and Morrison, A.R. (1996b). Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1 β-induced activation of NF-κ B in rat mesangial cells. Biochem. Biophys. Res. Commun 218, 808-812.
49. Traenckner, E.B.M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., and Baeuerle, P.A. (1995). Phosphorylation of human IkappaB-α on serines 32 and 36 controls IkappaB-α proteolysis and NF-κ B activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
50. Tsujii, M., and DuBois, R.N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
51. Umansky, V., Hehner, S.P., Dumont, A., Hofmann, T.G., Schirrmacher, V., Droge, W., and Schmitz, M.L. (1998). Costimulatory effect of nitric oxide on endothelial NF-kappaB implies a physiological self-amplifying mechanism. Eur. J. Immunol. 28, 2276-2282.
52. Vane, J.R., Mitchell, J.A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D.A. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91, 2046-2050.
53. von Knethen, A., and Brüne, B. (1997). Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J. 11, 887-895.
54. von Knethen, A., Lotero, A., and Brüne, B. (1998). Etoposide and cisplatin induced apoptosis in activated RAW264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene 17, 387-394.
55. Wang, C.Y., Mayo, M.W., and Baldwin, A.S., Jr. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
56. Wiseman, H., and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313, 17-29.
57. Xie, W., Fletcher, B.S., Andersen, R.D., and Herschman, H.R. (1994). v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell. Biol. 14, 6531-6539.
58. Xie, W., and Herschman, H.R. (1995). v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Chem. 270, 27622-27628.
59. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. (1995). Transcriptional roles of nuclear factor κ B and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315-31320.